Annual Report & AGM Notice
Poolbeg Pharma PLC has announced that its Annual Report and Accounts for the period ending 31 December 2025, along with the notice for its Annual General Meeting, will be posted to shareholders on 7 May 2026. The company, focused on transforming cancer immunotherapy and developing an oral GLP-1 therapy for obesity, will hold its AGM on 9 June 2026 at Aldgate Tower, London. The full report will be available on the company's website.
Select text to share a quote on X · sign in to keep highlights & notes in your POLB notes
7 May 2026 - Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, confirms that the Company's Annual Report and Accounts for the period ended 31 December 2025 and the notice of Annual General Meeting ("AGM") will be posted to shareholders today.
The Annual Report and Accounts, the Notice of AGM and accompanying form of proxy will shortly be available to download from the Company's website: https://www.poolbegpharma.com/
The Annual General Meeting will be held at the offices of Gravita at Aldgate Tower, 2 Leman Street, London, E1 8FA on 9 June 2026 at 12 noon.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.